Stock listing
LS Exchange:900964 Neurocrine Biosciences, Inc. Aktie
German listing (LS Exchange) of Neurocrine Biosciences, Inc. · home listing NASDAQ:NBIX
Follow Neurocrine Biosciences, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:NBIX
$142.00 USD +5.02 (+3.7%)
Close on Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:NBIX
- Day range
- $137.90 – $142.09 USDOct 20, 2026
- Volume
- 1.25M sharesOct 20, 2026
- Market cap
- $14.43B USDAt the close on Oct 20, 2026 · price × 101.6M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NBIX · Home | $142.00 USD | +5.02 (+3.7%) | 1,252,508 | $138.51 | $142.09 | $137.90 | $136.98 | Close on Oct 20, 2026 |
| Frankfurt:NB3 | €120.50 EUR | -0.30 (-0.2%) | — | €120.50 | €120.50 | €120.50 | €120.80 | Close on Oct 20, 2026 |
| LSE:0K6R | $141.32 USD | +4.48 (+3.3%) | 288 | $139.01 | $141.84 | $135.48 | $136.84 | Close on Oct 20, 2026 |
| B3:N1BI34 | 34.86 BRL | +0.12 (+0.3%) | 11 | 34.17 | 34.86 | 34.17 | 34.74 | Close on Oct 19, 2026 |
| Munich:NB3 | €121.60 EUR | 0.00 (0.0%) | — | €121.60 | €121.60 | €121.60 | €121.60 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NASDAQ:NBIX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $142.00 | +5.02 | +3.7% | $138.51 | $142.09 | $137.90 | 1,252,508 | |
| $136.98 | +1.27 | +0.9% | $136.56 | $137.52 | $135.01 | 1,012,981 | |
| $135.71 | -1.24 | -0.9% | $137.86 | $138.20 | $135.55 | 1,076,612 | |
| $136.95 | +1.04 | +0.8% | $137.26 | $138.23 | $135.55 | 1,326,096 | |
| $135.91 | +0.78 | +0.6% | $133.94 | $136.57 | $132.25 | 1,506,700 | |
| $135.13 | -6.24 | -4.4% | $139.60 | $139.93 | $134.89 | 1,562,062 | |
| $141.37 | -1.07 | -0.8% | $142.37 | $143.63 | $140.89 | 1,092,100 | |
| $142.44 | +1.19 | +0.8% | $141.33 | $143.55 | $140.02 | 1,019,500 | |
| $141.25 | -2.22 | -1.5% | $142.88 | $143.02 | $140.34 | 1,237,200 | |
| $143.47 | -2.04 | -1.4% | $145.33 | $145.88 | $143.21 | 1,143,700 | |
| $145.51 | +1.30 | +0.9% | $145.56 | $145.77 | $141.39 | 1,449,500 | |
| $144.21 | +1.03 | +0.7% | $142.94 | $146.92 | $142.48 | 1,748,200 | |
| $143.18 | +2.47 | +1.8% | $141.41 | $144.56 | $140.36 | 1,648,200 | |
| $140.71 | -1.13 | -0.8% | $140.94 | $143.74 | $139.61 | 2,052,000 | |
| $141.84 | +3.49 | +2.5% | $138.33 | $142.91 | $137.63 | 1,847,000 | |
| $138.35 | -2.09 | -1.5% | $138.26 | $141.07 | $136.31 | 1,499,000 | |
| $140.44 | +2.04 | +1.5% | $137.76 | $140.59 | $136.78 | 1,423,500 | |
| $138.40 | -0.54 | -0.4% | $138.94 | $138.94 | $137.02 | 1,171,000 | |
| $138.94 | -0.55 | -0.4% | $138.54 | $140.63 | $137.00 | 1,169,100 | |
| $139.49 | -2.76 | -1.9% | $141.97 | $142.25 | $139.32 | 1,747,700 | |
| $142.25 | -1.71 | -1.2% | $144.17 | $144.26 | $141.78 | 1,213,700 | |
| $143.96 | -2.27 | -1.6% | $146.15 | $146.26 | $143.45 | 1,385,300 | |
| $146.23 | -5.60 | -3.7% | $152.63 | $152.63 | $146.06 | 2,815,400 | |
| $151.83 | +2.33 | +1.6% | $151.14 | $152.07 | $149.71 | 1,178,300 | |
| $149.50 | -0.52 | -0.3% | $150.34 | $151.31 | $149.00 | 1,015,400 | |
| $150.02 | -7.20 | -4.6% | $156.70 | $156.70 | $149.15 | 1,332,100 | |
| $157.22 | +1.00 | +0.6% | $158.00 | $159.19 | $156.57 | 785,500 | |
| $156.22 | -0.35 | -0.2% | $157.20 | $159.67 | $156.12 | 890,900 | |
| $156.57 | +1.43 | +0.9% | $154.38 | $159.94 | $152.04 | 895,200 | |
| $155.14 | +0.01 | 0.0% | $154.61 | $155.55 | $152.38 | 1,050,700 | |
| $155.13 | -0.51 | -0.3% | $153.99 | $156.82 | $151.77 | 818,700 | |
| $155.64 | -2.71 | -1.7% | $158.24 | $159.80 | $154.83 | 933,400 | |
| $158.35 | +0.56 | +0.4% | $159.93 | $159.93 | $156.76 | 758,300 | |
| $157.79 | +1.03 | +0.7% | $157.39 | $160.43 | $155.09 | 1,037,900 | |
| $156.76 | +2.73 | +1.8% | $154.31 | $157.03 | $153.70 | 878,400 | |
| $154.03 | -0.03 | 0.0% | $153.11 | $155.00 | $151.77 | 1,741,100 | |
| $154.06 | -1.86 | -1.2% | $155.92 | $156.57 | $153.08 | 813,000 | |
| $155.92 | -0.67 | -0.4% | $155.28 | $156.75 | $154.61 | 730,300 | |
| $156.59 | +3.22 | +2.1% | $153.21 | $159.40 | $152.02 | 1,119,100 | |
| $153.37 | +0.33 | +0.2% | $153.84 | $156.13 | $152.01 | 1,041,866 | |
| $153.04 | +0.47 | +0.3% | $152.57 | $154.56 | $151.77 | 1,207,968 | |
| $152.57 | -0.36 | -0.2% | $153.13 | $155.27 | $152.51 | 1,227,600 | |
| $152.93 | -2.61 | -1.7% | $154.99 | $155.81 | $152.50 | 870,700 | |
| $155.54 | +1.31 | +0.8% | $156.56 | $156.56 | $154.34 | 1,162,800 | |
| $154.23 | -0.26 | -0.2% | $155.92 | $156.24 | $153.46 | 1,037,500 | |
| $154.49 | +1.77 | +1.2% | $151.62 | $154.81 | $150.69 | 1,169,000 | |
| $152.72 | +1.90 | +1.3% | $149.72 | $153.42 | $148.78 | 1,305,100 | |
| $150.82 | -5.67 | -3.6% | $154.43 | $155.81 | $150.20 | 2,055,700 | |
| $156.49 | -5.45 | -3.4% | $159.74 | $159.98 | $154.86 | 2,094,100 | |
| $161.94 | -2.98 | -1.8% | $165.46 | $165.46 | $161.78 | 808,100 | |
| $164.92 | +1.51 | +0.9% | $161.52 | $165.15 | $161.52 | 935,200 | |
| $163.41 | +3.59 | +2.2% | $161.53 | $164.76 | $159.68 | 971,000 | |
| $159.82 | -1.68 | -1.0% | $161.28 | $162.51 | $158.48 | 1,366,100 | |
| $161.50 | -4.56 | -2.7% | $168.55 | $168.55 | $161.30 | 1,292,000 | |
| $166.06 | -0.17 | -0.1% | $166.89 | $169.02 | $165.71 | 1,197,300 | |
| $166.23 | -0.57 | -0.3% | $166.25 | $170.88 | $164.01 | 1,515,900 | |
| $166.80 | -18.70 | -10.1% | $184.34 | $185.55 | $164.56 | 4,584,200 | |
| $185.50 | +4.71 | +2.6% | $179.00 | $186.12 | $176.60 | 2,170,900 | |
| $180.79 | -2.04 | -1.1% | $182.00 | $183.50 | $180.00 | 1,071,900 | |
| $182.83 | +6.42 | +3.6% | $178.84 | $182.91 | $176.25 | 1,333,100 | |
| $176.41 | +0.64 | +0.4% | $176.46 | $179.15 | $176.00 | 1,047,900 | |
| $175.77 | +1.62 | +0.9% | $174.25 | $177.30 | $173.43 | 1,129,500 | |
| $174.15 | +1.46 | +0.8% | $170.67 | $174.99 | $170.00 | 1,103,200 | |
| $172.69 | -6.36 | -3.6% | $178.87 | $181.00 | $171.81 | 1,192,000 | |
| $179.05 | +6.05 | +3.5% | $174.77 | $179.05 | $174.10 | 1,305,400 | |
| $173.00 | +2.12 | +1.2% | $172.37 | $174.59 | $171.70 | 977,500 |
- Ticker
- LS Exchange:900964
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- LS Exchange
- Currency
- EUR
What changed lately
Latest news release · Oct 20, 2026
Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-'567 in Adults with Alzheimer's Disease
Latest earnings call · Jul 30, 2026
Neurocrine Biosciences (NASDAQ:NBIX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · May 5, 2026
Q1 2026 Earnings Presentation
Earnings · 15 slides
Calls
Upcoming
Neurocrine Biosciences (NASDAQ:NBIX) Q3 2026 Earnings Call
Mon, Nov 02, 2026 · 4:30 PM ET
Register
Replays
Neurocrine Biosciences (NASDAQ:NBIX) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 4:30 PM ET
Watch TranscriptNeurocrine Biosciences (NASDAQ:NBIX) Q1 2026 Earnings Call
Tue, May 05, 2026 · 4:30 PM ET
Watch TranscriptNeurocrine Biosciences (NASDAQ:NBIX) Q4 2025 Earnings Call
Wed, Feb 11, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-'567 in Adults with Alzheimer's Disease
Oct 20, 2026
Closed $142.00 (+3.7%) on Oct 20, 2026
Neurocrine Biosciences Presents Real-World Evidence Mapping the Lifelong, Evolving Impact of Classic Congenital Adrenal Hyperplasia
Oct 16, 2026
Closed $135.71 (-0.9%) on Oct 16, 2026
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2026 Financial Results
Oct 12, 2026
Closed $135.13 (-4.4%) on Oct 13, 2026
Neurocrine Biosciences to Present Research Advancing Understanding of Prader-Willi Syndrome and Real-World Experience with VYKAT® XR (diazoxide choline) at Foundation for Prader-Willi Research Symposium & Family Conference
Sep 30, 2026
Closed $141.84 (+2.5%) on Sep 30, 2026
Neurocrine Biosciences Appoints Eiry W. Roberts, M.D., as Chief Medical Officer
Sep 28, 2026
Closed $138.35 (-1.5%) on Sep 29, 2026
Neurocrine Biosciences Announces Publication of KINECT-PRO™ Findings Demonstrating INGREZZA® (valbenazine) Capsules Improved Patient-Reported Quality of Life and Daily Functioning for People Living with Tardive Dyskinesia
Aug 12, 2026
Closed $156.49 (-3.4%) on Aug 12, 2026
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-'1968, a GLP-1/GIP/Glucagon Receptor Triple Agonist
Aug 7, 2026
Closed $163.41 (+2.2%) on Aug 7, 2026
Neurocrine Biosciences Reports Second-Quarter 2026 Financial Results
Jul 30, 2026
Closed $166.80 (-10.1%) on Jul 31, 2026
Neurocrine Biosciences Announces Key Leadership Hiring, Promotions
Jul 23, 2026
Closed $175.77 (+0.9%) on Jul 24, 2026
Neurocrine Biosciences Appoints Samir Siddhanti Chief Business Officer
Jul 21, 2026
Closed $172.69 (-3.6%) on Jul 22, 2026
Decks
Q1 2026 Earnings Presentation
Earnings · 15 slides · May 5, 2026
Merger or Acquisition (April 2026)
Merger or acquisition · 12 slides · Apr 6, 2026
Q4 2025 Earnings Presentation
Earnings · 71 slides · Feb 11, 2026
Q3 2025 Earnings Presentation
Earnings · 48 slides · Oct 28, 2025
Neurocrine Biosciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 51 in the last 12 months · 274 in all · newest Oct 20, 2026 · oldest 2019
- Calls
- 16 calls with a replay · 16 with a transcript · latest Jul 30, 2026
- Decks
- 7 decks · latest May 5, 2026
Where Neurocrine Biosciences, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NBIX · Home listing | NASDAQ | United States | USD |
| gettex:NB3 | gettex | Germany | EUR |
| Lang & Schwarz:900964 | Lang & Schwarz | Germany | EUR |
| Frankfurt:NB3 | Frankfurt | Germany | EUR |
| LS Exchange:900964 · This page | LS Exchange | Germany | EUR |
| BMV:NBIX | BMV | Mexico | MXN |
| LSE:0K6R | LSE | United Kingdom | USD |
| B3:N1BI34 | B3 | Brazil | BRL |
| Tradegate:NB3 | Tradegate | Germany | EUR |
| Milan:1NBIX | Milan | Italy | EUR |
| BIVA:NBIX | BIVA | Mexico | MXN |
| BOATS:NBIX | BOATS | United States | USD |
| BX Swiss:NB3 | BX Swiss | Switzerland | CHF |
| Dusseldorf:NB3 | Dusseldorf | Germany | EUR |
| Munich:NB3 | Munich | Germany | EUR |
| Stuttgart:NB3 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Neurocrine Biosciences, Inc.